Replies to post #110426 on Biotech Values

[DewDiligence]

(Corrected)—MNTA’s offering=4.6M* shares @$14.35=net proceeds of ~$66M*:

http://finance.yahoo.com/news/Momenta-Pharmaceuticals-pz-1201481171.html?x=0&.v=1

This is an expansion of about 9% in MNTA's share count for valuation purposes (#msg-42163809).

*Assuming exercise of underwriter's 30-day option for 600K shares.